haylaavo

ORCHIDPHAR

ORCHIDPHAR · NSE · inactive
5.45
-0.25 (-4.39%)
as of 24 Jul 2019 close
Open
5.60
High
5.60
Low
5.45
Prev close
5.70
52w high
8.70
01 Aug 2018
52w low
3.00
20 Feb 2019
VWAP
5.45
Delivery %
—
n/a
Volume 21,970 · turnover ₹1.20 L · NSE bhavcopy (official close) · history since 21 Dec 2015
Series
BZ
F&O
No
Status
Inactive since 02 Apr 2019

Formerly ORCHIDCHEM (until 21 Dec 2015). Earlier name: Orchid Chemicals & Pharmaceuticals Limited (until 21 Dec 2015).

Source: NSE equity master · as of 01 Apr 2019

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 22:41 IST
  • 05 Oct 2020 19:00
    Compliance

    Orchid Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 30 Sept 2020 21:03
    Compliance

    Orchid Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

    PDF · -
  • 06 Jul 2020 15:23
    Compliance

    Orchid Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 01 Jul 2020 18:52
    Compliance

    Orchid Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

    PDF · -
  • 03 Apr 2020 13:41
    Compliance

    Orchid Pharma Limited has informed the Exchange regarding Newspaper advertisement of the Notice given to Shareholders for Record Date

    PDF · -
  • 01 Apr 2020 21:32
    Compliance

    Intimation about trading window closure

    PDF · -
  • 10 Dec 2019 12:30
    Compliance

    Orchid Pharma Limited has informed the Exchange regarding Disclosure of Related Party Transaction under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    PDF · -
  • 28 Jun 2019 18:52
    Compliance

    Orchid Pharma Limited has informed the Exchange regarding Disclosure for Related Party Transactions under Regulation 23(9) of SEBI (LODR) regulations, 2015 for the half year ended March 31,2019

    PDF · -
  • 27 May 2019 20:10
    Compliance

    Orchid Pharma Limited has informed the Exchange regarding Outcome of Committee Meeting held on May 24, 2019.

    PDF · -
  • 04 Apr 2019 18:56
    Compliance

    Orchid Pharma Limited has informed the Exchange regarding the Code of Conduct under SEBI(PIT) Reg., 2015

    PDF · -
  • 23 Feb 2017 13:04
    Compliance

    Orchid Pharma Limited has informed the Exchange regarding Intimation of Change in Name of Registry activity of our Registrar and Share Transfer Agent.

    PDF · -
  • 18 May 2016 10:40
    Compliance

    Orchid Pharma Limited has informed the Exchange that the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of the Company shall remain closed for all the insiders from May 18, 2016 to May 30, 2016 (both days inclusive).

    PDF · -
  • 27 Oct 2015 08:48
    Compliance

    Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that the members of the Company at the Annual General Meeting held on September 15, 2015 have approved to change the name of the Company to "Orchid Pharma Limited" and the special resolution was passed with requisite majority. Based on this, the Company had made an application to Registrar of Companies, Tamilnadu, for change of name and the Registrar of Companies have approved the change in the name of the Company to "Orchid Pharma Limited."

    PDF · -
  • 27 Jul 2015 16:58
    Compliance

    Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that the Board has approved the Code of practices and procedures for fair disclosure of unpublished price sensitive information (UPSI).

    PDF · -
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries